Lv0
0 积分 2025-01-29 加入
Analysis of Risk Factors for Hepatotoxicity Induced by Immune Checkpoint Inhibitors
7小时前
待确认
Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study
8小时前
已完结
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors: should we take the risk?
8小时前
已完结
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinoma
8小时前
已完结
Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study
9小时前
已完结
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trial
1天前
已完结
皖公网安备34019202002308
